- 3.9Impact Factor
- 6.8CiteScore
- 18 daysTime to First Decision
State-of-the-Art Molecular and Translational Medicine in Poland, 3rd Edition
This special issue belongs to the section “Molecular and Translational Medicine“.
Special Issue Information
Dear Colleagues,
New therapeutic approaches require the knowledge and skills of multiple disciplines. The comprehensive exploration of biological mechanisms and the molecular pathogenesis of major human diseases enables personalized treatment. The integration of omics approaches in combination with modeling approaches and systems biology may play a crucial role in establishing novel clinical applications. Furthermore, the sequencing of individual human genomes has provided an opportunity to develop pharmacogenetics in routine medical practice in order to avoid side effects, and choose the most effective drug and dose according to each individual genotype.
For this Special Issue, we seek papers focused on the mechanisms associated with the development of diseases, including cell-to-cell metabolic crosstalk in physiology, pathology and cancer research. New insights into the molecular mechanisms related to therapy effectiveness and changes in gene expression that have important implications for understanding genotype–phenotype maps are also of importance. There is no doubt that further knowledge is required for the future development of clinically relevant guidelines and new methods for the early detection, prevention, treatment and prognosis of diseases.
Dr. Małgorzata Wrzosek
Dr. Arkadiusz Kocur
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- molecular medicine
- molecular mechanisms
- disease pathogenesis
- genetic variants
- gene expression
- epigenetics
- metabolic disorders
- cancer
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

